Invention Grant
- Patent Title: Olanzapine pamoate dihydrate
- Patent Title (中): 奥氮平双羟萘酸二水合物
-
Application No.: US11722228Application Date: 2005-12-22
-
Publication No.: US07932249B2Publication Date: 2011-04-26
- Inventor: Julie Kay Bush
- Applicant: Julie Kay Bush
- Applicant Address: US IN Indianapolis
- Assignee: Eli Lilly and Company
- Current Assignee: Eli Lilly and Company
- Current Assignee Address: US IN Indianapolis
- Agent Ted Joseph Ebersole; Nelsen L. Lentz
- International Application: PCT/US2005/046752 WO 20051222
- International Announcement: WO2006/073886 WO 20060713
- Main IPC: A61P25/18
- IPC: A61P25/18 ; A61K31/5513 ; C07D495/04
Abstract:
The present invention relates olanzapine pamoate dihydrate, pharmaceutical compositions thereof and use in treating certain mental disorders, such as schizophrenia.
Public/Granted literature
- US20080096871A1 Olanzapine Pamoate Dihydrate Public/Granted day:2008-04-24
Information query
